Anavex Life Sciences Corp. Profile Avatar - Palmy Investing

Anavex Life Sciences Corp.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial…

Biotechnology
US, New York [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Competitor Private? Source Accuracy Country City
- - - -
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of AVXL's Analysis
CIK: 1314052 CUSIP: 032797300 ISIN: US0327973006 LEI: - UEI: -
Secondary Listings
AVXL has no secondary listings inside our databases.